Table 1. National age specific incidence of herpes zoster and post herpetic neuralgia based on extrapolated BEACH data.
| Age | BEACH database April 2000 – September 2006 1 | BEACH database October 2006 – March 2013 | ||||||
|---|---|---|---|---|---|---|---|---|
| Population (2004) 2 | New zoster/PHN encounters recorded | Estimated new zoster/PHN cases (National annual estimates) 3 (95% CI) | Estimated new zoster/PHN cases per 1,000 persons 4 (95% CI) | Population (2007–12) 5 | New zoster/PHN encounters recorded | Estimated new zoster/PHN cases (National annual estimates) 6 (95% CI) | Estimated new zoster/PHN cases per 1,000 persons 7 (95% CI) | |
| Herpes Zoster | ||||||||
| <25 | 6,741,520 | 61 | 9,391 (6,894 – 11,887) | 1.39 (1.02 – 1.76) | 7,187,000 | 69 | 12,740 (9,660 – 15,820) | 1.77 (1.34 – 2.20) |
| 25–49 | 7,314,664 | 163 | 25,093 (21,241 – 28,945) | 3.43 (2.90 – 3.96) | 7,747,655 | 149 | 27,510 (23,000 – 32,020) | 3.55 (2.97 – 4.13) |
| 50–59 | 2,525,527 | 107 | 16,450 (13,300–19,650) | 6.52 (5.26 – 7.78) | 2,756,079 | 94 | 17,350 (13,870 – 20,840) | 6.30 (5.03 – 7.56) |
| 60–69 | 1,651,276 | 92 | 14,150 (11,200 – 17,150) | 8.58 (6.78 – 10.37) | 2,053,592 | 152 | 28,060 (23,600 – 32,530) | 13.66 (11.49 – 15.84) |
| 70–79 | 1,178,105 | 111 | 17,100 (13,750 – 20,450) | 14.50 (11.66 – 17.35) | 1,253,830 | 104 | 19,200 (15,470 – 22,930) | 15.31 (12.34– 18.29) |
| 80+ | 680,412 | 69 | 10,600 (8,150 – 13,100) | 15.61 (11.95 – 19.28) | 807,600 | 87 | 16,060 (12,670 – 19,450) | 19.89 (15.69– 24.08) |
| Post Herpetic Neuralgia | ||||||||
| <25 | 6,741,520 | 4 | 616 (12–1219) | 0.09 (0–0.18) | 7,187,000 | 1 | 180 (0–550) | 0.03 (0–0.08) |
| 25–49 | 7,314,664 | 3 | 461 (0–984) | 0.06 (0–0.13) | 7,747,655 | 8 | 1,480 (450–2500) | 0.19 (0.06–0.32) |
| 50–59 | 2,525,527 | 12 | 1,850 (800–2,900) | 0.73 (0.32–1.15) | 2,756,079 | 15 | 2,770 (1,370–4170) | 1.01 (0.50–1.51) |
| 60–69 | 1,651,276 | 13 | 2,000 (900–3,100) | 1.21 (0.55–1.88) | 2,053,592 | 23 | 4,250 (2,510–5,980) | 2.07 (1.22–2.91) |
| 70–79 | 1,178,105 | 18 | 2,750 (1,500–4,050) | 2.35 (1.26–3.44) | 1,253,830 | 23 | 4,250 (2,510–5,980) | 3.39 (2.00–4.77) |
| 80+ | 680,412 | 14 | 2,150 (1,050–3,300) | 3.16 (1.54–4.85) | 807,600 | 23 | 4,250 (2,510–5,980) | 5.26 (3.11–7.40) |
BEACH: Bettering the Evaluation and Care of Health; 95% CI: 95% Confidence interval. Bolded data in table indicates statistically significant results.
1. Data for the 50–59, 60–69, 70–79,80+ and 50+ age groups reproduced from Table 3 in (Stein et al 2009).
2. Australian Bureau of Statistics (ABS). Series B projections by age and sex. Australian Bureau of Statistics, 2007, available at http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3222.02004%20to%202101?OpenDocument.
3. Based on the rate of encounters for new herpes zoster problems extrapolated to national annual average of 99.45 million general practice encounters.
4. Calculation based on the 2004 Australian population (reproduces the data from (Stein et al 2009).
5. Average estimated resident population from 2007 to 2012. Australian Bureau of Statistics (ABS). 3101.0—Australian Demographic Statistics, Jun 2013. 2013, available at http://www.abs.gov.au/ausstats/abs@.nsf/mf/3101.0.
6. Based on the rate of encounters for new herpes zoster or PHN problems extrapolated to national annual average of 116.35 million general practice encounters.
7. Calculation based on the average estimated resident population of Australia from 2007 to 2012.